Table 1 Frequency of cytogenetic abnormalities by iFISH in different subgroups

From: Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era

Cytogenetic abnormalities by iFISH (N=742)

CPCs absent (n=678)

CPCs present (n=162)

P-value

Deletion 17p, n (%)

65 (11.0)

24 (15.9)

0.107

t(4;14), n (%)

43 (7.3)

25 (16.6)

<0.001

t(14;16), n (%)

22 (3.7)

6 (4.0)

0.883

t(14; 20), n (%)

6 (1.0)

2 (1.3)

0.747

+1q, n (%)

29 (4.9)

8 (5.3)

0.845

Deletion 13q or monosomy 13

244 (41.3)

84 (55.6)

0.002

  1. Abbreviations: CPC, circulating plasma cell; iFISH, interphase fluorescence in situ hybridization; N, number of patients with available data on iFISH cytogenetics. Bold values indicate statistically significance parameters.